Clinical studies suggest that apelin is related to the diagnosis and prognosis of cerebral ischemia, while studies in animal and cellular models indicate that exogenous apelin-13 can effectively reduce infarct volume and cerebral edema, and improve neurological function after cerebral ischemia. This evidence concerns the gene APLN and brain ischemia.